Results 181 to 190 of about 8,310 (238)

Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Mexico: a systematic review. [PDF]

J Comp Eff Res
Ceballos Ruiz C, Navarro A.
europepmc   +1 more source

Inhaled Corticosteroid/Long-Acting β₂-Agonist Selection for Patients with Moderate-to-Severe Asthma: Considerations for Real-World Practice, A Narrative Review. [PDF]

Adv Ther
Blakey JD, Cecchi L, Domingo C, D'Urzo TD, Singh D, Verma M.   +5 more
europepmc   +1 more source

Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews. [PDF]

BMJ Open
Al-Khayat Z, Franzen N, Retèl VP, Van Harten WH.   +3 more
europepmc   +1 more source

CPX-351 in secondary/high-risk acute myeloid leukemia: a meta-analysis of randomized and real-world studies encompassing more than 3,200 patients. [PDF]

Haematologica
Molica M, Giannarelli D, De Fazio L, Rossi M, Perrone S.   +4 more
europepmc   +1 more source

RWE in Europe Paper IV: Engaging pharma in the RWE Roadmap

, 2018
openaire   +1 more source

Real‑World Clinical Characterization of Major Depressive Disorder and Treatment‑Resistant Depression Supported by Natural Language Processing: Multicenter Observational Study From the MOOD Project. [PDF]

Interact J Med Res
Zeeuws D, Bernagie K, De Bruecker G, Claeys I, Evenepoel C, Ver Donck F, Smeets D, Peeters E.   +7 more
europepmc   +1 more source

Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia. [PDF]

Front Pharmacol
Sukkarieh HH, Al Fayez N, Al-Omar HA, Azmi NO, Syed B, Albar RA, Al Bali N.   +6 more
europepmc   +1 more source